FI903509A0 - NYTT HETRAZEPIN MED PAF-ANTAGONISTISK EFFEKT, FOERFARANDE FOER DESS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL. - Google Patents

NYTT HETRAZEPIN MED PAF-ANTAGONISTISK EFFEKT, FOERFARANDE FOER DESS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.

Info

Publication number
FI903509A0
FI903509A0 FI903509A FI903509A FI903509A0 FI 903509 A0 FI903509 A0 FI 903509A0 FI 903509 A FI903509 A FI 903509A FI 903509 A FI903509 A FI 903509A FI 903509 A0 FI903509 A0 FI 903509A0
Authority
FI
Finland
Prior art keywords
hetrazepin
antagonistisk
nytt
effekt
paf
Prior art date
Application number
FI903509A
Other languages
Finnish (fi)
Inventor
Karl-Heinz Weber
Werner Stransky
Gerhard Walther
Ulrike Kuefner-Muehl
Hubert Heuer
Franz Birke
Gojko Muacevic
Wolf-Dietrich Bechtel
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of FI903509A0 publication Critical patent/FI903509A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/49—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with carbon monoxide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
FI903509A 1989-07-12 1990-07-11 NYTT HETRAZEPIN MED PAF-ANTAGONISTISK EFFEKT, FOERFARANDE FOER DESS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL. FI903509A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3922944 1989-07-12
DE4011345 1990-04-07

Publications (1)

Publication Number Publication Date
FI903509A0 true FI903509A0 (en) 1990-07-11

Family

ID=25882911

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903509A FI903509A0 (en) 1989-07-12 1990-07-11 NYTT HETRAZEPIN MED PAF-ANTAGONISTISK EFFEKT, FOERFARANDE FOER DESS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.

Country Status (14)

Country Link
EP (1) EP0407955A1 (en)
JP (1) JPH03215489A (en)
KR (1) KR910002863A (en)
AU (1) AU636155B2 (en)
CA (1) CA2020806A1 (en)
FI (1) FI903509A0 (en)
HU (1) HUT59144A (en)
IE (1) IE902526A1 (en)
IL (1) IL95045A0 (en)
NO (1) NO903088L (en)
NZ (1) NZ234476A (en)
PL (1) PL286019A1 (en)
PT (1) PT94673A (en)
YU (1) YU133090A (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95708C (en) * 1988-10-31 1996-03-11 Eisai Co Ltd Analogous process for preparing a 1,4-diazepine derivative and its pharmaceutically acceptable salt
DE4027470A1 (en) * 1990-08-30 1992-03-05 Boehringer Ingelheim Kg NEW HETRAZEPINOIDE AMIDE
DE4101146A1 (en) * 1991-01-16 1992-07-23 Boehringer Ingelheim Kg NEW DIAZEPINE SUBSTITUTED IN 6-POSITION, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICAMENT
DE4107521A1 (en) * 1991-03-08 1992-09-10 Boehringer Ingelheim Kg NEW ACYLAMINOSUBSTITUTED HETRAZEPINE
DE69717160T2 (en) * 1996-09-13 2003-05-08 Mitsubishi Pharma Corp THIENOTRIAZOLODIAZEPINE COMPOUNDS AND THEIR MEDICAL APPLICATIONS
US5939432A (en) 1997-10-29 1999-08-17 Medco Research, Inc. Thiophenes useful for modulating the adenosine receptor
US6323214B1 (en) 1997-10-29 2001-11-27 Medco Research, Inc Allosteric adenosine receptor modulators
US6727258B2 (en) 1997-10-29 2004-04-27 King Pharmaceutical Research & Development, Inc. Allosteric adenosine receptor modulators
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
JP5008796B2 (en) * 2001-01-19 2012-08-22 ダイト株式会社 Method for producing aromatic carboxylic acid
JP5159305B2 (en) * 2005-05-30 2013-03-06 田辺三菱製薬株式会社 Thienotriazolodiazepine compounds and their use as pharmaceuticals
ES2534521T3 (en) 2010-05-14 2015-04-23 Dana-Farber Cancer Institute, Inc. Compositions and their use in the treatment of neoplasia, inflammatory diseases and other diseases
EP2571875A4 (en) 2010-05-14 2013-10-30 Dana Farber Cancer Inst Inc Male contraceptive compositions and methods of use
AU2011252799B2 (en) 2010-05-14 2015-05-14 Cold Spring Harbor Laboratory Compositions and methods for treating leukemia
AR084070A1 (en) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc BROMODOMINIUM INHIBITORS AND USES OF THE SAME
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2721031B1 (en) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (en) 2012-06-06 2017-10-21 星宿藥物公司 Bromodomain inhibitors and uses thereof
EP2864336B1 (en) 2012-06-06 2016-11-23 Constellation Pharmaceuticals, Inc. Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
KR20160034379A (en) 2013-07-25 2016-03-29 다나-파버 캔서 인스티튜트 인크. Inhibitors of transcription factors and uses thereof
CN105849110B (en) 2013-11-08 2019-08-02 达纳-法伯癌症研究所有限公司 Use the combination treatment for cancer of bromine structural domain and additional terminals (BET) protein inhibitor
US10793571B2 (en) 2014-01-31 2020-10-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
CA2936865A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
MX2016011160A (en) 2014-02-28 2017-04-27 Tensha Therapeutics Inc Treatment of conditions associated with hyperinsulinaemia.
CA2952830C (en) 2014-06-20 2022-11-01 Constellation Pharmaceuticals, Inc. Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
WO2016022970A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Dihydropteridinone derivatives and uses thereof
CN106715437A (en) 2014-08-08 2017-05-24 达纳-法伯癌症研究所股份有限公司 Diazepane derivatives and uses thereof
EP3212654B1 (en) 2014-10-27 2020-04-08 Tensha Therapeutics, Inc. Bromodomain inhibitors
US10702527B2 (en) 2015-06-12 2020-07-07 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
CN108472300A (en) 2015-09-11 2018-08-31 达纳-法伯癌症研究所股份有限公司 Cyano thiophene and triazol diazacyclo heptantriene and application thereof
JP2018526424A (en) 2015-09-11 2018-09-13 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド Acetamidhienotriazolodiazepines and their use
SG10201913450PA (en) 2015-11-25 2020-03-30 Dana Farber Cancer Inst Inc Bivalent bromodomain inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2712951A1 (en) * 1977-03-24 1978-10-05 Bosch Gmbh Robert BIMETAL WITH AN ELECTRIC HEATING ELEMENT
DE3701344A1 (en) * 1986-01-21 1987-07-23 Boehringer Ingelheim Kg Novel thieno-1,4-diazepines
DE3778559D1 (en) * 1986-01-21 1992-06-04 Boehringer Ingelheim Kg THIENO-1,4-DIAZEPINE.
DE3610848A1 (en) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg NEW 1,4-DIAZEPINE
DE3724031A1 (en) * 1986-07-22 1988-01-28 Boehringer Ingelheim Kg Novel hetrazepines and process for their preparation
DE3624779C2 (en) * 1986-07-22 1996-03-07 Boehringer Ingelheim Kg Process for the preparation of thieno-triazolo-1,4-diazepino-2-carboxylic acid amides

Also Published As

Publication number Publication date
HUT59144A (en) 1992-04-28
KR910002863A (en) 1991-02-26
EP0407955A1 (en) 1991-01-16
CA2020806A1 (en) 1991-01-13
NZ234476A (en) 1992-08-26
IE902526A1 (en) 1991-02-13
NO903088L (en) 1991-01-14
PT94673A (en) 1991-03-20
NO903088D0 (en) 1990-07-11
IL95045A0 (en) 1991-06-10
AU636155B2 (en) 1993-04-22
AU5892490A (en) 1991-01-17
YU133090A (en) 1993-10-20
JPH03215489A (en) 1991-09-20
PL286019A1 (en) 1991-10-21
HU904169D0 (en) 1990-12-28

Similar Documents

Publication Publication Date Title
FI903509A0 (en) NYTT HETRAZEPIN MED PAF-ANTAGONISTISK EFFEKT, FOERFARANDE FOER DESS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
FI894148A (en) RAOMATERIAL, FOERFARANDE FOER DESS FRAMSTAELLNING OCH DESS ANVAENDNING.
FI900125A0 (en) POSITIVE ARRANGEMENTS STRAOLNINGSKAENSLIG BLANDNING INNEHAOLLANDE EN FLERFUNKTIONELL A-DIAZO-B-KETOESTER, FOERFARANDE FOER DESS FRAMSTAELLNING OCH STAOLNINGSKAENSLIGT REGISTRERINGSMATERIAL SOM INNEHAOLLER DENNA
FI902248A0 (en) N-HETEROARYL-4-QUINOLINAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
FI900537A0 (en) ELEKTRICITET LEDANDE RESISTMASSA, FOERFARANDE FOER DESS FRAMSTAELLNING OCH DESS ANVAENDNING.
FI906139A (en) HALOGENERADE OLEFINER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA SOM SKADEDJURSBEKAEMPNINGSMEDEL.
FI921279A0 (en) AMINO-B-LYASENZYMINHIBITORER SOM DEODORANTER.
FI900762A0 (en) TRIS-HYDROXIMETYLALKANESTRAR SOM FETTIMITATIONER MED LAOG KALORIHALT.
FI900763A0 (en) TRIS-HYDROXIMETYL-LAEGRE ALKANESTRAR SOM FETTSURROGAT.
FI894742A0 (en) ELLEDANDE PLASTKOMPOSIT, DESS ANVAENDNING OCH FRAMSTAELLNING.
FI892214A (en) KOPPARLEGERING FOER ANVAENDNING SOM MOTSTAONDSSVETSELEKTROD.
FI903214A0 (en) NAFTYL- OCH NAFTYLOXI- PYRIMIDINER OCH DESSA BEROERANDE FOERENINGAR, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM DERMATOLOGISKA LAEKEMEDEL.
FI895483A (en) SOM SLAGLOD ANVAENDBARA KOPPARBLANDNINGAR.
FI905689A (en) 3-AMINOPYRROLER, FOERFARANDEN FOER DERAS FRAMSTAELLNING, OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
FI904660A0 (en) SOM FUNGICIDER ANVAENDBARA SUBSTITUERADE TRIAZOLER, DERAS FRAMSTAELLNING OCH KOMPOSITIONER.
FI905702A (en) KUMARINDERIVAT, FOERFARANDE FOER FRAMSTAELLNING AV DESSA, ANVAENDNING AV DESSA OCH TIAZOLYLAETTIKSSYRADERIVAT SOM MELLANPRODUKTER.
FI902852A0 (en) RENININHIBITORISKA PEPTIDER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL.
FI902199A0 (en) 5-SUBSTITUERADE 3-ARYL-ISOXAZOLDERIVAT, DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM SKADEDJURSBEKAEMPNINGSMEDEL.
FI900940A0 (en) TRYCKT KRETSSKIVA SOM FOERHINDRAR ELEKTROMAGNETISK INTERFERENS.
FI903851A0 (en) VINYLIDEN- OCH ETYLENFLUORIDKOPOLYMER, DESS FRAMSTAELLNINGSFOERFARANDE OCH TILLAEMPNING SOM ADHESIONMEDIUM.
FI905238A0 (en) FOERBRAENNINGSMOTOR FOER FARTYG SOM TRANSPORTERAR FOERBRAENNINGSGAS.
FI903790A0 (en) FLUORANFOERENING, FOERFARANDE FOER DESS FRAMSTAELLNING OCH DENNA FOERENING INNEHAOLLANDE VAERMEKAENSLIGA UPPTAGNINGSMATERIAL.
FI921687A0 (en) OXIDERINGSFAERGNINGSMEDEL, DESS FRAMSTAELLNING OCH ANVAENDNING.
FI920474A0 (en) ELEKTROPOTOGRAFISKT FRAMSTAELLD TRYCKPLATTA, MED HYDROFILA TONADE OMRAODEN OCH OLEOFILISKA OTONADE OMRAODEN.
FI900102A0 (en) 7-ARYL- OCHHETEROARYLETRAR AV DESACETYLFORSKOLIN, FOERFRANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDING SOM LAEKEMEDEL.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM KG